7092512

CD279 Mouse anti-Human, FITC, Clone: MIH4, BD

Mouse Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

CD279

Concentration

0.5mg/mL

Classification

Monoclonal

Host Species

Mouse

Target Species

Human

Immunogen

Human PD-1 Transfected Cell Line

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Clone

MIH4

Applications

Flow Cytometry

Conjugate

FITC

Regulatory Status

RUO

Formulation

Aqueous buffered solution containing ≤0.09% sodium azide.

Isotype

IgG1 κ

Purification Method

Affinity Purified

Description

PD-1; hPD-1; PD1; PDCD1; Programmed cell death 1; SLEB2

Related Products

Img

Fischer Scientific

7092511

Hamster Monoclonal Antibody...

Img

Fischer Scientific

7092394

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7092394

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7092451

Rat Monoclonal Antibody...

Img

Fischer Scientific

7092689

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7092689

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7092693

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7092441

Mouse Monoclonal Antibody...

Description

  • The MIH4 monoclonal antibody specifically binds to the program death 1 (PD-1) receptor CD279, a member of the Ig superfamily
  • CD279 is an immunoregulatory receptor expressed on activated T cells, B cells and myeloid cells
  • Mice deficient in CD279 show a breakdown of peripheral tolerance and manifest multiple autoimmune symptoms
  • It contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic region
  • PD-L1 and PD-L2 are ligands of CD279 and are members of the B7 gene family
  • Interaction of CD279:PD-Ligands results in inhibition of T cell proliferation and cytokine secretion
  • Reports suggest that the B7/CTLA-4 pathway functions primarily to attenuate, limit, and/or terminate naοve T-cell activation in secondary lymphoid organs
  • The PD-ligand:CD279 pathway, on the other hand, may primarily attenuate, limit, and/or terminate T-, B-, and myeloid cell activation/effector function at sites of inflammation in the periphery.